These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8343286)

  • 1. A phase II study of etoposide, cisplatin plus methotrexate in patients with advanced refractory breast cancer.
    Jouve M; Dorval T; Mosseri V; Palangie T; Beuzeboc P; Garcia-Giralt E; Livartowski A; Scholl S; Pouillart P
    Eur J Cancer; 1993; 29A(9):1355. PubMed ID: 8343286
    [No Abstract]   [Full Text] [Related]  

  • 2. Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer.
    Içli F; Günel N; Dinçol D; Karaoğuz H; Demirkazik A
    J Surg Oncol; 1992 Aug; 50(4):251-3. PubMed ID: 1640710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of 4-epirubicin, etoposide and cisplatin as neoadjuvant chemotherapy in locally advanced breast cancer.
    Costa MA; Lamarca JE; Bader GR
    Eur J Cancer; 1994; 30A(6):891. PubMed ID: 7917557
    [No Abstract]   [Full Text] [Related]  

  • 4. [New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
    Ikeda I; Shuin T; Yao M; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1993 Mar; 39(3):237-42. PubMed ID: 7685142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CEM chemotherapy (cisplatin, etoposide, methotrexate) for advanced urothelial cancer].
    Moriyama M; Murai T; Kondo I
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):297-9. PubMed ID: 2301954
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of cisplatin and etoposide as first-line therapy in metastatic breast carcinoma.
    Lluch A; Azagra P; Cervantes A; Muñoz M; Alberola V; Santabarbara P; García-Conde J
    Oncology; 1994; 51(4):352-5. PubMed ID: 8208520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum and etoposide in chemotherapy refractory metastatic breast cancer. A phase II trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
    Cocconi G; Tonato M; Di Costanzo F; Bisagni G; Belsanti V; Buzzi F; Ceci G
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):761-4. PubMed ID: 3770033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapy.
    Gridelli C; Contegiacomo A; Lauria R; Gentile M; Airoma G; De Placido S; Perrone F; Ferrante G; Bianco AR
    Tumori; 1991 Dec; 77(6):506-10. PubMed ID: 1666468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
    Mao Y; Wan X; Lv W; Xie X
    Int J Gynaecol Obstet; 2007 Jul; 98(1):44-7. PubMed ID: 17481633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
    Cocconi G; Bisagni G; Bacchi M; Boni C; Bartolucci R; Ceci G; Colozza MA; De Lisi V; Lottici R; Mosconi AM
    J Clin Oncol; 1991 Apr; 9(4):664-9. PubMed ID: 2066763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MEC treatment (methotrexate, etoposide, cisplatin) for urothelial cancer].
    Miura T; Murai T; Shimura H; Kondo I
    Gan To Kagaku Ryoho; 1992 May; 19(5):731-3. PubMed ID: 1580650
    [No Abstract]   [Full Text] [Related]  

  • 12. [MEP (methotrexate, etoposide and cisplatin) and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced uroepithelial cancer--a preliminary report of MEP as second line chemotherapy for recurrence after M-VAC].
    Seguchi T; Nakano E; Miki T; Kondoh M; Nishimura K; Nakamura N; Okuyama A
    Gan To Kagaku Ryoho; 1994 Jan; 21(1):59-65. PubMed ID: 8291917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial ischemia after treatment with methotrexate, etoposide and cisplatin.
    Igawa M; Kadena H; Ohkuchi T; Ueda M; Usui T; Matsuura H
    Urol Int; 1993; 50(2):98-100. PubMed ID: 8460457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-D, etoposide, cisplatin (EMA/EP).
    Bilgin T; Ozan H; Ozuysal S; Ozkan L
    Arch Gynecol Obstet; 2004 Jan; 269(2):159-60. PubMed ID: 14648186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide (VP-16-213) and cis-dichlorodiammineplatinum (DDP) in advanced breast carcinoma resistant to previous chemotherapy.
    Athanassiades P; Bacoyiannes H; Kontoyiannes D
    Chemioterapia; 1986 Apr; 5(2):125-7. PubMed ID: 3518965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial.
    Goto K; Ohe Y; Shibata T; Seto T; Takahashi T; Nakagawa K; Tanaka H; Takeda K; Nishio M; Mori K; Satouchi M; Hida T; Yoshimura N; Kozuki T; Imamura F; Kiura K; Okamoto H; Sawa T; Tamura T;
    Lancet Oncol; 2016 Aug; 17(8):1147-1157. PubMed ID: 27312053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer.
    Somlo G; Doroshow JH; Forman SJ; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Akman SA; Ahn C; Sniecinski I
    Cancer; 1994 Jan; 73(1):125-34. PubMed ID: 7903906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results of methotrexate, etoposide and cisplatin in the treatment of urothelial cancer.
    Igawa M; Kadena H; Tacho T; Nakamoto T; Usui T
    Urol Int; 1995; 54(2):80-4. PubMed ID: 7747364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
    Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
    Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.